Dr. Jeffrey D. Knispel, MD

Dr. Knispel practices at Dermatology Associates of Western Connecticut in Newtown, Connecticut.

Dr. Knispel's NPI, 1710983036, was assigned on June 22, 2005. Dr. Knispel graduated from Icahn School of Medicine at Mount Sinai in 1995. Dr. Knispel holds Connecticut license 038731.

Dr. Knispel's primary practice is Dermatology Associates of Western Connecticut, at 170 Mt Pleasant Rd, Newtown, CT 06470 in Western Ct County. The practice phone is (203) 792-4151.

Dr. Knispel's primary practice is Dermatology Associates of Western Connecticut in Newtown, Connecticut. Dr. Knispel is also affiliated with Northwell Danbury Hospital. The medical group on file is Dermatology Associates of Western Connecticut. Dmand AI also links Dr. Knispel to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Knispel practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Knispel's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Knispel is licensed in Connecticut.

CMS data shows 5,960 Medicare services from Dr. Knispel across 36 procedure codes in 2024, for 1,607 Medicare patients. Medicare paid $300,187 for them. Every service was in an office.

CMS counts 1,607 Medicare patients who saw Dr. Knispel in 2024. The largest group is 65 to 74, with 678 patients. 75% of them have high cholesterol, and 67% have high blood pressure. 7% are also on Medicaid. Their average risk score is 1.08, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Knispel's median patient age at 60, with 50% women.

In 2024, Dr. Knispel wrote 1,883 Medicare Part D claims for 783 patients. 90% of them were for generic drugs. CMS names the drug for 1,674 of them, across 30 drugs with 11 or more claims each, at $681,402 in total drug cost. In 2023, CMS named 1,620 claims across 33 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Knispel for performance year 2024, reported as part of a group. Dr. Knispel accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 1,313 procedures of removal of skin lesions by Dr. Knispel, more than 95% of the clinicians it reports for that procedure.

Dmand AI links 1 paper to Dr. Knispel in 2016. Dr. Knispel's most frequent co-author is Emily Sara Yin, MD.

Dmand AI links Dr. Knispel to 1 clinical trial. Conditions studied include Psoriasis and Skin Diseases, Papulosquamous. Open Payments lists research payments to Dr. Knispel that name 1 trial.

CMS Open Payments shows 2,085 general payments to Dr. Knispel from 59 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 63% of the total. Abbvie Inc. paid the most, $5,498. It also lists 26 research payments totaling $53,820 from 2016 to 2023, naming 1 clinical trial.

Dr. Knispel graduated from Icahn School of Medicine at Mount Sinai in 1995.